# Watts Water Technologies Inc: financial statements, quarterly WTS · NYSE · CIK 795403 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/wts.md) · [Financials](/companies/wts/financials.md) · [Filings](/companies/wts/filings.md) · [Insiders](/companies/wts/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wts/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [504](/filings/0001558370-24-014022.md) | [548 d](/filings/0001104659-26-018541.md) | [571](/filings/0001558370-25-006887.md) | [597](/filings/0001558370-25-010686.md) | [544](/filings/0001104659-25-107489.md) | [540 d](/filings/0001104659-26-018541.md) | [558](/filings/0001104659-26-056817.md) | [644](/filings/0001104659-26-091726.md) | [612](/filings/0001104659-25-107489.md) | [625 d](/filings/0001104659-26-018541.md) | [677](/filings/0001104659-26-056817.md) | [763](/filings/0001104659-26-091726.md) | | Cost of revenue | $m | [270](/filings/0001558370-24-014022.md) | [292 d](/filings/0001104659-26-018541.md) | [303](/filings/0001558370-25-006887.md) | [313](/filings/0001558370-25-010686.md) | [287](/filings/0001104659-25-107489.md) | [288 d](/filings/0001104659-26-018541.md) | [286](/filings/0001104659-26-056817.md) | [318](/filings/0001104659-26-091726.md) | [313](/filings/0001104659-25-107489.md) | [316 d](/filings/0001104659-26-018541.md) | [351](/filings/0001104659-26-056817.md) | [389](/filings/0001104659-26-091726.md) | | Gross profit | $m | [234](/filings/0001558370-24-014022.md) | [256 d](/filings/0001104659-26-018541.md) | [268](/filings/0001558370-25-006887.md) | [285](/filings/0001558370-25-010686.md) | [257](/filings/0001104659-25-107489.md) | [253 d](/filings/0001104659-26-018541.md) | [273](/filings/0001104659-26-056817.md) | [326](/filings/0001104659-26-091726.md) | [298](/filings/0001104659-25-107489.md) | [309 d](/filings/0001104659-26-018541.md) | [326](/filings/0001104659-26-056817.md) | [374](/filings/0001104659-26-091726.md) | | Research and development | $m | [15.2](/filings/0001558370-24-014022.md) | [19.8 d](/filings/0001104659-26-018541.md) | [18.5](/filings/0001558370-25-006887.md) | [17.9](/filings/0001558370-25-010686.md) | [17.6](/filings/0001104659-25-107489.md) | [16.4 d](/filings/0001104659-26-018541.md) | [16.8](/filings/0001104659-26-056817.md) | [17.4](/filings/0001104659-26-091726.md) | [18.8](/filings/0001104659-25-107489.md) | [20.6 d](/filings/0001104659-26-018541.md) | [19.2](/filings/0001104659-26-056817.md) | [20.9](/filings/0001104659-26-091726.md) | | Selling, general and administrative | $m | [147](/filings/0001558370-24-014022.md) | [173 d](/filings/0001104659-26-018541.md) | [170](/filings/0001558370-25-006887.md) | [173](/filings/0001558370-25-010686.md) | [159](/filings/0001104659-25-107489.md) | [163 d](/filings/0001104659-26-018541.md) | [168](/filings/0001104659-26-056817.md) | [187](/filings/0001104659-26-091726.md) | [185](/filings/0001104659-25-107489.md) | [195 d](/filings/0001104659-26-018541.md) | [193](/filings/0001104659-26-056817.md) | [215](/filings/0001104659-26-091726.md) | | Operating income | $m | [87.1](/filings/0001558370-24-014022.md) | [78.7 d](/filings/0001104659-26-018541.md) | [96.7](/filings/0001558370-25-006887.md) | [112](/filings/0001558370-25-010686.md) | [93.2](/filings/0001104659-25-107489.md) | [89.0 d](/filings/0001104659-26-018541.md) | [87.7](/filings/0001104659-26-056817.md) | [135](/filings/0001104659-26-091726.md) | [111](/filings/0001104659-25-107489.md) | [114 d](/filings/0001104659-26-018541.md) | [133](/filings/0001104659-26-056817.md) | [154](/filings/0001104659-26-091726.md) | | Interest expense | $m | [1.2](/filings/0001558370-23-017345.md) | [3.8 d](/filings/0001104659-26-018541.md) | [4.2](/filings/0001558370-25-006887.md) | [4.1](/filings/0001558370-25-010686.md) | [3.6](/filings/0001104659-25-107489.md) | [2.8 d](/filings/0001104659-26-018541.md) | [2.7](/filings/0001104659-26-056817.md) | [2.7](/filings/0001104659-26-091726.md) | [2.7](/filings/0001104659-25-107489.md) | [2.7 d](/filings/0001104659-26-018541.md) | [2.6](/filings/0001104659-26-056817.md) | [2.2](/filings/0001104659-26-091726.md) | | Income tax | $m | [22.3](/filings/0001558370-24-014022.md) | [21.6 d](/filings/0001104659-26-018541.md) | [22.6](/filings/0001558370-25-006887.md) | [27.5](/filings/0001558370-25-010686.md) | [23.2](/filings/0001104659-25-107489.md) | [21.4 d](/filings/0001104659-26-018541.md) | [12.9](/filings/0001104659-26-056817.md) | [33.8](/filings/0001104659-26-091726.md) | [28.8](/filings/0001104659-25-107489.md) | [29.5 d](/filings/0001104659-26-018541.md) | [31.8](/filings/0001104659-26-056817.md) | [35.4](/filings/0001104659-26-091726.md) | | Net income | $m | [65.8](/filings/0001558370-24-014022.md) | [55.7 d](/filings/0001104659-26-018541.md) | [72.6](/filings/0001558370-25-006887.md) | [82.0](/filings/0001558370-25-010686.md) | [69.1](/filings/0001104659-25-107489.md) | [67.6 d](/filings/0001104659-26-018541.md) | [74.0](/filings/0001104659-26-056817.md) | [101](/filings/0001104659-26-091726.md) | [82.2](/filings/0001104659-25-107489.md) | [83.7 d](/filings/0001104659-26-018541.md) | [99.6](/filings/0001104659-26-056817.md) | [118](/filings/0001104659-26-091726.md) | | Diluted EPS | $ per share | [1.96](/filings/0001558370-24-014022.md) | not reported | [2.17](/filings/0001558370-25-006887.md) | [2.44](/filings/0001558370-25-010686.md) | [2.06](/filings/0001104659-25-107489.md) | not reported | [2.21](/filings/0001104659-26-056817.md) | [3.01](/filings/0001104659-26-091726.md) | [2.45](/filings/0001104659-25-107489.md) | not reported | [2.97](/filings/0001104659-26-056817.md) | [3.53](/filings/0001104659-26-091726.md) | | Basic EPS | $ per share | [1.97](/filings/0001558370-24-014022.md) | not reported | [2.17](/filings/0001558370-25-006887.md) | [2.44](/filings/0001558370-25-010686.md) | [2.07](/filings/0001104659-25-107489.md) | not reported | [2.21](/filings/0001104659-26-056817.md) | [3.01](/filings/0001104659-26-091726.md) | [2.45](/filings/0001104659-25-107489.md) | not reported | [2.97](/filings/0001104659-26-056817.md) | [3.53](/filings/0001104659-26-091726.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [363](/filings/0001558370-23-017345.md) | [350](/filings/0001558370-25-001102.md) | [237](/filings/0001558370-24-007502.md) | [279](/filings/0001558370-24-011496.md) | [304](/filings/0001558370-24-014022.md) | [387](/filings/0001104659-26-018541.md) | [337](/filings/0001558370-25-006887.md) | [369](/filings/0001558370-25-010686.md) | [458](/filings/0001104659-25-107489.md) | [406](/filings/0001104659-26-091726.md) | [375](/filings/0001104659-26-056817.md) | [348](/filings/0001104659-26-091726.md) | | Current assets | $m | [1,042](/filings/0001558370-23-017345.md) | [1,061](/filings/0001558370-25-001102.md) | [1,010](/filings/0001558370-24-007502.md) | [1,061](/filings/0001558370-24-011496.md) | [1,066](/filings/0001558370-24-014022.md) | [1,084](/filings/0001104659-26-018541.md) | [1,108](/filings/0001558370-25-006887.md) | [1,214](/filings/0001558370-25-010686.md) | [1,314](/filings/0001104659-25-107489.md) | [1,286](/filings/0001104659-26-091726.md) | [1,348](/filings/0001104659-26-056817.md) | [1,366](/filings/0001104659-26-091726.md) | | Total assets | $m | [2,309](/filings/0001558370-24-014022.md) | [2,309](/filings/0001104659-26-018541.md) | [2,332](/filings/0001558370-24-007502.md) | [2,383](/filings/0001558370-24-011496.md) | [2,399](/filings/0001558370-24-014022.md) | [2,397](/filings/0001104659-26-018541.md) | [2,501](/filings/0001558370-25-006887.md) | [2,645](/filings/0001558370-25-010686.md) | [2,725](/filings/0001104659-25-107489.md) | [2,881](/filings/0001104659-26-091726.md) | [2,940](/filings/0001104659-26-056817.md) | [2,952](/filings/0001104659-26-091726.md) | | Current liabilities | $m | [380](/filings/0001558370-23-017345.md) | [406](/filings/0001558370-25-001102.md) | [407](/filings/0001558370-24-007502.md) | [425](/filings/0001558370-24-011496.md) | [418](/filings/0001558370-24-014022.md) | [418](/filings/0001104659-26-018541.md) | [450](/filings/0001558370-25-006887.md) | [468](/filings/0001558370-25-010686.md) | [464](/filings/0001104659-25-107489.md) | [512](/filings/0001104659-26-091726.md) | [496](/filings/0001104659-26-056817.md) | [513](/filings/0001104659-26-091726.md) | | Long-term debt | $m | [98.2](/filings/0001558370-23-017345.md) | [298](/filings/0001558370-25-001102.md) | [284](/filings/0001558370-24-007502.md) | [259](/filings/0001558370-24-011496.md) | [212](/filings/0001558370-24-014022.md) | [197](/filings/0001104659-26-018541.md) | [197](/filings/0001558370-25-006887.md) | [197](/filings/0001558370-25-010686.md) | [198](/filings/0001104659-25-107489.md) | [198](/filings/0001104659-26-091726.md) | [198](/filings/0001104659-26-056817.md) | [108](/filings/0001104659-26-091726.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,452](/filings/0001558370-24-014022.md) | [1,513](/filings/0001104659-26-018541.md) | [1,552](/filings/0001558370-25-010686.md) | [1,618](/filings/0001104659-25-107489.md) | [1,689](/filings/0001104659-25-107489.md) | [1,708](/filings/0001104659-26-091726.md) | [1,772](/filings/0001104659-26-091726.md) | [1,892](/filings/0001104659-26-091726.md) | [1,957](/filings/0001104659-25-107489.md) | [2,028](/filings/0001104659-26-091726.md) | [2,096](/filings/0001104659-26-091726.md) | [2,189](/filings/0001104659-26-091726.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [100 d](/filings/0001558370-24-014022.md) | [110 d](/filings/0001104659-26-018541.md) | [45.6](/filings/0001558370-25-006887.md) | [85.3 d](/filings/0001558370-25-010686.md) | [90.7 d](/filings/0001104659-25-107489.md) | [140 d](/filings/0001104659-26-018541.md) | [55.2](/filings/0001104659-26-056817.md) | [69.7 d](/filings/0001104659-26-091726.md) | [122 d](/filings/0001104659-25-107489.md) | [155 d](/filings/0001104659-26-018541.md) | [17.9](/filings/0001104659-26-056817.md) | [103 d](/filings/0001104659-26-091726.md) | | Capital expenditure | $m | [7.4 d](/filings/0001558370-24-014022.md) | [10.7 d](/filings/0001104659-26-018541.md) | [10.1](/filings/0001558370-25-006887.md) | [6.8 d](/filings/0001558370-25-010686.md) | [6.4 d](/filings/0001104659-25-107489.md) | [12.0 d](/filings/0001104659-26-018541.md) | [9.6](/filings/0001104659-26-056817.md) | [10.2 d](/filings/0001104659-26-091726.md) | [11.5 d](/filings/0001104659-25-107489.md) | [14.4 d](/filings/0001104659-26-018541.md) | [11.3](/filings/0001104659-26-056817.md) | [11.3 d](/filings/0001104659-26-091726.md) | | Share repurchases | $m | [4.0 d](/filings/0001558370-24-014022.md) | [4.3 d](/filings/0001104659-26-018541.md) | [4.0](/filings/0001558370-25-006887.md) | [4.1 d](/filings/0001558370-25-010686.md) | [4.9 d](/filings/0001104659-25-107489.md) | [4.0 d](/filings/0001104659-26-018541.md) | [3.9](/filings/0001104659-26-056817.md) | [4.0 d](/filings/0001104659-26-091726.md) | [3.9 d](/filings/0001104659-25-107489.md) | [4.2 d](/filings/0001104659-26-018541.md) | [3.8](/filings/0001104659-26-056817.md) | [4.1 d](/filings/0001104659-26-091726.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [33.5](/filings/0001558370-23-017345.md) | [33.5](/filings/0001558370-24-007502.md) | [33.6](/filings/0001558370-24-011496.md) | [33.5](/filings/0001558370-24-014022.md) | [33.5](/filings/0001558370-25-006887.md) | [33.5](/filings/0001558370-25-010686.md) | [33.5](/filings/0001104659-25-107489.md) | [33.5](/filings/0001104659-26-056817.md) | [33.5](/filings/0001104659-26-091726.md) | [33.5](/filings/0001104659-25-107489.md) | [33.5](/filings/0001104659-26-056817.md) | [33.5](/filings/0001104659-26-091726.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.